Vijayakumar Velu PhD

Has grant

Assistant Professor

Emory University

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Vijayakumar Velu is an Assistant Professor at Emory University in the United States. His research areas include viral infections, immunology, and public health, with recent articles exploring topics such as HCV vaccine development, the role of NK cells in HIV infection, and public health implications of the Mpox virus. Dr. Velu's work further examines the interactions between various viral pathogens and the immune response, contributing to the understanding of chronic viral infections and their management.

Recent Grants

Grant: Close

Combined cytokine therapy for sustained HIV remission

Open Date: 2020-03-17

Close Date: 2025-02-28

Grant: Close

CD40L adjuvanted clade C DNA and MVA HIV vaccines

Open Date: 2014-03-15

Close Date: 2020-02-29

Articles (22)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (2)

Marie Larsson

Professor

Linköping University

SWEDEN

View details

Kirk Easley

Research Professor

Emory University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Vijayakumar Velu PhD

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (22)

Discovery of HCV vaccine: Where do we stand?

Role of follicular homing natural killer cells in HIV infection

Mpox Virus as a Global Public Health Emergency: A Scoping Review

IL-15/IL-15Ra Synergies with IL-12 to Induce Functional CD8 T Cells and NK Cells During Chronic SHIV Infection

Occult hepatitis B virus infection and current perspectives on global WHO 2030 eradication

Genomic surveillance of omicron B.1.1.529 SARS‐CoV‐2 and its variants between December 2021 and March 2023 in Tamil Nadu, India—A state‐wide prospective longitudinal study

Attrition in serum anti-DENV antibodies correlates with high anti-SARS-CoV-2 IgG levels and low DENV positivity in mosquito vectors—Findings from a state-wide cluster-randomized community-based study in Tamil Nadu, India

Differential expression of HIV target cells CCR5 and α4β7 in tissue resident memory CD4 T cells in endocervix during the menstrual cycle of HIV seronegative women

Emergence of SARS-CoV-2 omicron variant JN.1 in Tamil Nadu, India - Clinical characteristics and novel mutations

Human Immunodeficiency Virus–Human Pegivirus Coinfected Individuals Display Functional Mucosal-Associated Invariant T Cells and Follicular T Cells Irrespective of PD-1 Expression

Chronic Viral Infection Compromises the Quality of Circulating Mucosal–Associated Invariant T Cells and Follicular T Helper Cells via Expression of Inhibitory Receptors

Clinical characteristics and novel mutations of omicron subvariant XBB in Tamil Nadu, India–a cohort study

Intradermal but not intramuscular modified vaccinia Ankara immunizations protect against intravaginal tier2 simian-human immunodeficiency virus challenges in female macaques

Editorial: CD4+ T cells in HIV: A Friend or a Foe?

COVID-19 vaccine induced poor neutralization titers for SARS-CoV-2 omicron variants in maternal and cord blood

Impact of COVID-19 Vaccination on Pregnant Women

Impact of COVID-19 Vaccination on Pregnant Women

Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome—An Extempore Game of Misfiring with Defense Arsenals

Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome-An Extempore Game of Misfiring with Defense Arsenals

Antibody response, neutralizing potency, and transplacental antibody transfer following <scp>SARS‐CoV</scp> ‐2 infection versus <scp>mRNA</scp> ‐1273, <scp>BNT162b2 COVID19</scp> vaccination in pregnancy

Antibody response, neutralizing potency, and transplacental antibody transfer following SARS-CoV-2 infection versus mRNA-1273, BNT162b2 COVID-19 vaccination in pregnancy

Plasma CXCL8 and MCP-1 as surrogate plasma biomarkers of latent tuberculosis infection among household contacts–A cross-sectional study

Collaborators (2)

Marie Larsson

Kirk Easley

Make your next move.